TerrAscend (TSNDF) Revenue (2021 - 2026)
TerrAscend's (TSNDF) quarterly Revenue came in at $65.5 million in Q1 2026, up 1.92% year-on-year from $64.3 million in Q1 2025, and down 0.92% on a QoQ basis from $66.1 million in Q4 2025.
TerrAscend (TSNDF) Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Revenue data on file, last reported at $65.5 million in Q1 2026.
- On a quarterly basis, Revenue rose 1.92% year-over-year to $65.5 million in Q1 2026; TTM through Mar 2026 was $261.8 million, a 0.5% change from a year earlier, with the FY2025 full-year figure at $260.6 million, down 2.81% from the prior year.
- Revenue for Q1 2026 stood at $65.5 million, down from $66.1 million in the prior quarter.
- Over the last five years, Revenue for TSNDF reached as high as $89.2 million in Q3 2023 and fell as low as $19.7 million in Q4 2023.
- Historically, Revenue has averaged $64.9 million across 5 years, with a median of $66.1 million in 2025.
- Across the five-year window, Revenue plunged 70.95% in 2023 and surged 236.49% in 2024, its largest moves.
- Year by year, Revenue stood at $68.0 million in 2022, then plunged by 70.95% to $19.7 million in 2023, then jumped by 236.49% to $66.4 million in 2024, then dropped by 0.45% to $66.1 million in 2025, then retreated by 0.92% to $65.5 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $65.5 million in Q1 2026, $66.1 million in Q4 2025, and $65.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | TerrAscend | 164.39 Mn | 163.91 Mn | 34.60 Mn | 65.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.54 Mn |
| Dec 31, 2025 | 66.15 Mn |
| Sep 30, 2025 | 65.10 Mn |
| Jun 30, 2025 | 65.01 Mn |
| Mar 31, 2025 | 64.30 Mn |
| Dec 31, 2024 | 66.45 Mn |
| Sep 30, 2024 | 65.16 Mn |
| Jun 30, 2024 | 67.20 Mn |
| Mar 31, 2024 | 80.63 Mn |
| Dec 31, 2023 | 19.75 Mn |
| Sep 30, 2023 | 89.24 Mn |
| Jun 30, 2023 | 72.12 Mn |
| Mar 31, 2023 | 69.40 Mn |
| Dec 31, 2022 | 67.98 Mn |
| Sep 30, 2022 | 66.24 Mn |
| Jun 30, 2022 | 64.22 Mn |
| Mar 31, 2022 | 49.06 Mn |
| Dec 31, 2021 | 25.20 Mn |
| Sep 30, 2021 | 49.14 Mn |
| Jun 30, 2021 | 61.98 Mn |